Trial Profile

A Randomized Controlled Study of Montelukast Plus Low Dose Inhaled Budesonide Versus Medium Dose Inhaled Budesonide on Asthma Control in Elderly Patients.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Montelukast (Primary) ; Budesonide
Indications Asthma
Focus Therapeutic Use
Acronyms ACEM

Most Recent Events

21 Feb 2012 Actual initiation date (Jul 2010) added as reported by ClinicalTrials.gov.
21 Feb 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
21 Feb 2012 Planned End Date changed from 1 Oct 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com